13D/13G Filings - Nascent Biotech Inc. (NBIO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-13
5:10 pm
Sale
2023-12-31 13G Nascent Biotech, Inc.
NBIO
YA II PN, Ltd. 0
0.000%
-13,358,683decrease
(Position Closed)
Filing
History
2023-04-14
1:51 pm
Purchase
2023-04-14 13D Nascent Biotech, Inc.
NBIO
Burke Robert David 21,272,889
16.700%
21,272,889increase
(New Position)
Filing
History
2023-01-03
4:09 pm
Purchase
2022-12-31 13G Nascent Biotech, Inc.
NBIO
YA II PN, Ltd. 13,358,683
9.990%
365,837increase
(+2.82%)
Filing
History
2022-08-31
6:45 pm
Purchase
2022-08-30 13G Nascent Biotech, Inc.
NBIO
YA II PN, Ltd. 12,992,846
9.990%
12,992,846increase
(New Position)
Filing
History
2021-06-21
06:10 am
Purchase
2021-05-28 13G Nascent Biotech, Inc.
NBIO
Lorio Sidney J Jr 7,281,249
6.800%
7,281,249increase
(New Position)
Filing
History